2018
DOI: 10.1016/j.bej.2018.06.014
|View full text |Cite
|
Sign up to set email alerts
|

Reengineering cell-free protein synthesis as a biosensor: Biosensing with transcription, translation, and protein-folding

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
29
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 44 publications
(31 citation statements)
references
References 67 publications
0
29
0
Order By: Relevance
“…It can detect more kinds of amino acids (Asp, Asn, Glu, and Gln) than the crude extract system, and the detection threshold is lower. [ 109 ]…”
Section: Applicationsmentioning
confidence: 99%
“…It can detect more kinds of amino acids (Asp, Asn, Glu, and Gln) than the crude extract system, and the detection threshold is lower. [ 109 ]…”
Section: Applicationsmentioning
confidence: 99%
“…Notably, genomic material withdrawal from chassis organism bestows circumstances in which desired synthesis reactions are achievable at high rates (Hodgman & Jewett, 2012). Thus, such features enable prevailing utilization of CFPS systems, which are also complementary to in vivo expression for various applications such as biocatalyst development (Rolf, Rosenthal, & Lütz, 2019), complex product fabrication (Chi, Wang, Li, Ren, & Huang, 2015), disease detection (Soltani, Davis, Ford, Nelson, & Bundy, 2018), glycoprotein synthesis (Jaroentomeechai et al, 2018), prototyping minimal cells (Yue, Zhu, & Kai, 2019), synthetic gene networks (Dubuc et al, 2019), as well as protein engineering (Hong, Kwon, & Jewett, 2014; Venkat, Chen, Gan, & Fan, 2019), among others (Table 1 and Figure 1).…”
Section: Cfps: From Test Tube Reactions To Cell‐free Expression In MImentioning
confidence: 99%
“…Notably, genomic material withdrawal from chassis organism bestows circumstances in which desired synthesis reactions are achievable at high rates . Thus, such features enable prevailing utilization of CFPS systems, which are also complementary to in vivo expression for various applications such as biocatalyst development (Rolf, Rosenthal, & Lütz, 2019), complex product fabrication (Chi, Wang, Li, Ren, & Huang, 2015), disease detection (Soltani, Davis, Ford, Nelson, & Bundy, 2018), glycoprotein synthesis (Jaroentomeechai et al, 2018), prototyping minimal cells (Yue, Zhu, & Kai, 2019), synthetic gene networks (Dubuc et al, 2019), as well as protein engineering (Hong, Kwon, & Jewett, 2014;Venkat, Chen, Gan, & Fan, Sheng, Lei, Yuan and Feng (2017) Functional CRISPR gene editing toolkit Marshall et al (2018) Pathway/network prototyping UDP-N-acetylglucosamine and UDP-GlcNAc pathway Zhou et al (2010) CRISPR-mediated gene activation and repression of the reporter and endogenous genes in mammalian cells Nakamura et al (2019) Protein engineering E. coli strain mutant for release factor 1 allows turning UAG termination codon into a sense codon for site-specific incorporation of nonnatural amino acids into proteins for selective conjugation with different biomolecules Adachi et al (2019) Incorporation of uAA AzF allows for site-specific mono and dipegylation of T4 Lysozyme Wilding et al (2018) Incorporating optimized nonnatural amino acids site-specifically, the feasibility of conjugating a DBCO-PEG-monomethyl auristatin (DBCO-PEG-MMAF) drug by para-azidomethyl-L-phenylalanine (pAMF) to the tumor-specific, Her2-binding IgG Trastuzumab Zimmerman et al (2014) Biosensing Cheomogenic detection of estrogenic endocrine disruptors (hERb) in human blood and urine Salehi et al (2018) Glycoengineering Site-specific controlled glycosylation of proteins (glycoproteins) using E. coli extracts enriched for oligosaccharyltransferases and lipidlinked oligosaccharides Jaroentomeechai et al (2018) Site-directed incorporation of AzF, as well as ppropargyloxyphenylalanine from Sf21 insect cell, extracts for engineered O-glycosylation site of EPO Zemella et al (2018) Protein evolution: ribosome display Protein-tRNA-ribosome-mRNA complex for affinity selection of the nascent peptides on an immobilized monoclonal antibody specific for the peptide dynorphin Mattheakis, Bhatt and Dower (1994) Protein evolution: mRNA display Protein-puromycin-mRNA complex Roberts...…”
Section: Simple Standard Batch Reactions In Test Tubesmentioning
confidence: 99%
“…Cell-free biosensors for various applications have been reviewed elsewhere [57] and we will focus on strategies applicable to metabolic engineering. In a recent study, a vanillin biosensor was developed in cell-free systems [58••].…”
Section: Custom-made Biosensors' New Application Domain: Cell-free Mementioning
confidence: 99%